A carregar...
Podoplanin: An emerging cancer biomarker and therapeutic target
Podoplanin (PDPN) is a transmembrane receptor glycoprotein that is upregulated on transformed cells, cancer associated fibroblasts and inflammatory macrophages that contribute to cancer progression. In particular, PDPN increases tumor cell clonal capacity, epithelial mesenchymal transition, migratio...
Na minha lista:
| Publicado no: | Cancer Sci |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5980289/ https://ncbi.nlm.nih.gov/pubmed/29575529 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.13580 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|